湖北均瑶大健康饮品股份有限公司 二〇二五年第三次临时股东会会议资料 湖北均瑶大健康饮品股份有限公司 二〇二五年第三次临时股东会 会议资料 | | | 湖北均瑶大健康饮品股份有限公司 二〇二五年第三次临时股东会会议资料 会议须知 湖北均瑶大健康饮品股份有限公司 二〇二五年第三次临时股东会会议资料 七、在股东会召开过程中，股东临时要求发言的应向股东会会 务组报名，并填写《股东意见征询单》，经股东会主持人许可后发 言。 为了维护全体股东的合法权益，确保股东会的正常秩序和议事 效率，保证股东会的顺利进行，根据中国证监会发布的《上市公司 股东会规则》、《湖北均瑶大健康饮品股份有限公司章程》（以下 简称"《公司章程》"）和《股东会议事规则》的规定，特制定本 须知，请出席股东会的全体人员遵照执行： 一、本公司根据《中华人民共和国公司法》、《中华人民共和 国证券法》、《上市公司股东会规则》、《公司章程》及《股东会 议事规则》的规定，认真做好召开股东会的各项工作。 二、本公司设立股东会会务组，具体负责股东会有关程序方面 的事宜。 三、本次股东会以现场会议形式召开。 四、为保证本次股东会的严肃性和正常秩序，切实维护股东的 合法权 ...

Core Insights - Junyao Health's stock price increased by 2.04% on October 21, reaching 7.49 CNY per share, with a market capitalization of 4.498 billion CNY [1] - The company has seen a year-to-date stock price increase of 20.57%, but a decline of 12.30% over the past 20 days [1] Financial Performance - For the first half of 2025, Junyao Health reported revenue of 766 million CNY, a year-on-year increase of 1.38%, while net profit attributable to shareholders decreased by 78.52% to 7.4661 million CNY [2] - Cumulative cash dividends since the company's A-share listing amount to 365 million CNY, with 132 million CNY distributed over the past three years [3] Shareholder Information - As of June 30, 2025, the number of shareholders increased by 58.20% to 42,700, while the average circulating shares per person decreased by 36.79% to 14,074 shares [2] - Tianhong Zhongzheng Food and Beverage ETF is among the top ten circulating shareholders, holding 831,800 shares as a new shareholder [3] Business Overview - Junyao Health, established on August 5, 1998, specializes in the research, production, and sales of room-temperature lactic acid bacteria beverages and other health drinks [1] - The company's revenue composition includes probiotic beverages (34.11%), commodity supply chain (34.07%), probiotic foods (21.98%), and other beverages and foods (9.55%) [1]

Core Insights - The beverage and dairy sector experienced a slight increase of 0.32% on October 16, with Dongpeng Beverage leading the gains [1] - The Shanghai Composite Index closed at 3916.23, up 0.1%, while the Shenzhen Component Index closed at 13086.41, down 0.25% [1] Sector Performance - Dongpeng Beverage (605499) closed at 297.90, with a rise of 2.07% and a trading volume of 16,700 shares, amounting to a transaction value of 496 million yuan [1] - Yili Group (600887) saw a closing price of 27.81, up 0.58%, with a trading volume of 368,500 shares and a transaction value of 1.025 billion yuan [1] - Other notable performances include Sanyuan Foods (600429) at 4.80 (+0.21%), and Bright Dairy (600597) at 8.57 (-0.12%) [1] Individual Stock Movements - The beverage and dairy sector saw significant declines in some stocks, such as Pinuo Food (300892) which fell by 4.52% to 34.87, with a trading volume of 55,100 shares and a transaction value of 195 million yuan [2] - Knight Dairy (920786) decreased by 4.40% to 10.00, with a trading volume of 106,800 shares and a transaction value of 109 million yuan [2] - Other stocks like Zhuangyuan Pasture (002910) and Yiming Food (605179) also experienced declines of 3.86% and 3.20%, respectively [2] Capital Flow Analysis - The beverage and dairy sector saw a net outflow of 179 million yuan from major funds, while retail investors contributed a net inflow of 193 million yuan [2] - The overall capital flow indicates a mixed sentiment within the sector, with institutional investors pulling back while retail investors showed interest [2]

Core Insights - The beverage and dairy sector experienced a slight increase of 0.19% on October 15, with Chengde Lulu leading the gains [1] - The Shanghai Composite Index closed at 3912.21, up 1.22%, while the Shenzhen Component Index closed at 13118.75, up 1.73% [1] Stock Performance - Chengde Lulu (000848) closed at 9.05, up 4.50%, with a trading volume of 568,100 shares and a transaction value of 509 million [1] - Miaokelan Duo (600882) closed at 27.01, up 3.73%, with a trading volume of 181,600 shares and a transaction value of 486 million [1] - Panda Dairy (300898) closed at 27.46, up 3.62%, with a trading volume of 98,300 shares and a transaction value of 274 million [1] - Other notable stocks include Yiming Food (605179) at 21.25 (+3.21%) and New Dairy (002946) at 18.10 (+2.55%) [1] Capital Flow - The beverage and dairy sector saw a net inflow of 250 million from main funds, while retail investors experienced a net outflow of 188 million [2] - Major stocks like Yili (600887) had a net inflow of 94.93 million from main funds, but a net outflow of 61.86 million from retail investors [3] - Chengde Lulu (000848) also saw a net inflow of 68.09 million from main funds, with retail investors withdrawing 31.43 million [3]

Group 1 - The core viewpoint of the news is that Junyao Health's stock has shown fluctuations in price and trading volume, with a year-to-date increase of 21.70% and a recent decline over the past 20 days of 16.00% [1] - As of October 15, Junyao Health's stock price was 7.56 CNY per share, with a market capitalization of 4.54 billion CNY and a trading volume of 49.31 million CNY [1] - The company has been active in the market, appearing on the trading leaderboard 11 times this year, with the most recent appearance on June 13 [1] Group 2 - Junyao Health operates in the food and beverage industry, specifically in the dairy sector, with a focus on the development, production, and sales of various health drinks, including probiotic beverages [2] - The company's revenue composition includes 34.11% from probiotic drinks, 34.07% from supply chain products, 21.98% from probiotic foods, and 9.55% from other beverages and foods [1] - As of June 30, the number of shareholders increased by 58.20% to 42,700, while the average number of circulating shares per person decreased by 36.79% to 14,074 shares [2] Group 3 - Junyao Health has distributed a total of 365 million CNY in dividends since its A-share listing, with 132 million CNY distributed over the past three years [3] - As of June 30, 2025, Tianhong Zhongzheng Food and Beverage ETF became a new major shareholder, holding 831,800 shares [3]

Core Insights - The article discusses the challenges faced by Junyao Health as consumer preferences shift towards low-sugar, additive-free, and functional products, leading to a decline in the sales of its flagship product, Weidongli [1][2][3] Group 1: Company Background and Historical Performance - Junyao Health was established in the 20th century, initially gaining popularity through policy benefits and advertising, and later transitioned to the health-focused yogurt market in 2004 [1] - The company launched Weidongli in 2011, which became a significant revenue driver, selling 5 billion bottles from 2014 to 2021 and contributing to its listing as the "first stock of ambient yogurt" [1][4] - However, the company has faced declining sales, with Weidongli's revenue dropping from 11.2 billion in 2017 to 7.54 billion in 2021, and a significant decline in yogurt sales from 2020 to 2023 [7][8] Group 2: Market Challenges and Consumer Trends - The high sugar content of yogurt products has led to a negative perception among health-conscious consumers, resulting in a shift away from traditional yogurt drinks [6][10] - The overall market for dairy beverages has contracted, with a nearly 13% decrease in market share reported in the second quarter of 2025 [8] - Junyao Health's attempts to innovate and expand its product lines have not yet yielded significant market acceptance, as evidenced by the lack of separate revenue reporting for Weidongli in recent financial statements [9][10] Group 3: Financial Performance and Strategic Shifts - In the first half of 2025, Junyao Health reported a revenue of 766 million, a year-on-year increase of 1.38%, but a net profit decline of 78.52% to 7.47 million [2] - The company has increased its marketing expenses significantly, with a 70.65% rise in sales and marketing costs, indicating a struggle to maintain profitability amid rising costs [10] - Despite the challenges in the yogurt segment, Junyao Health is pivoting towards the probiotic market, which has shown substantial growth potential, with an expected market size of 137.7 billion by 2026 [11][12] Group 4: Future Strategies and Market Positioning - Junyao Health aims to leverage its extensive strain library and partnerships with top universities to enhance its probiotic offerings, although it faces stiff competition from established international brands [13][16] - The company is focusing on both B2B and B2C strategies, aiming to provide customized services to dairy and health product companies while also targeting consumer health segments through innovative marketing [19] - The success of Junyao Health's future strategies hinges on effective consumer education and differentiation in a crowded market, as well as the establishment of a strong brand identity around its proprietary strains [18][19]

（文章来源：证券日报） 证券日报网讯 10月13日晚间，均瑶健康发布公告称，2025年10月10日，公司召开职工代表大会并做出 决议，选举王晨晨女士为第五届董事会职工董事。 ...

Group 1 - The core point of the article is that Junyao Health announced the convening of its 17th board meeting for the fifth session, where it reviewed the proposal for appointing the auditing firm for the fiscal year 2025 [1] - Junyao Health's revenue composition for the year 2024 is as follows: beverage industry accounts for 46.11%, supply chain industry for 39.89%, food industry for 13.65%, and other businesses for 0.35% [1] - As of the report date, Junyao Health has a market capitalization of 4.4 billion yuan [1]

湖北均瑶大健康饮品股份有限公司 股东会议事规则 第一章 总则 第一条 为提高湖北均瑶大健康饮品股份有限公司（以下称"公司"）股东 会议事效率，保证股东会会议程序及决议的合法性，充分维护全体股东的合法权 益，根据《中华人民共和国公司法》（以下称"《公司法》"）、《中华人民共和国 证券法》（以下简称"《证券法》"）、《上市公司章程指引》、《上市公司股东会规则》、 《上海证券交易所股票上市规则》、《湖北均瑶大健康饮品股份有限公司章程》（以 下称"《公司章程》"）及其他有关法律、法规和规范性文件的规定，制定本议 事规则（以下称"本规则"）。 第二条 公司股东会是公司的最高权力机构，应在第一条规定的法律、法规、 规范性文件、《公司章程》及本规则规定的职权范围内行使职权。 第三条 公司董事会应当切实履行职责，认真、按时组织股东会。公司全体 董事应当勤勉尽责，确保股东会正常召开和依法履行职权。 第二章 股东会的一般规定 第四条 公司股东会依法行使下列职权： （一）决定公司在一年内购买或出售资产超过公司最近一期经审计资产总 额 30%的事项； （二）决定本规则第七条规定的担保事项； （三）选举和更换非由职工代表担任的公司董事 ...

投资者关系管理制度 第一章 总则 第一条 为了加强湖北均瑶大健康饮品股份有限公司(以下简称"公司") 与投资者和潜在投资者(以下合称"投资者")之间的信息沟通，建立公司与投资 者特别是广大社会公众投资者的良好沟通平台，完善公司治理结构，切实保护投 资者特别是中小投资者的合法权益，形成公司与投资者之间长期、稳定、和谐的 良性互动关系，根据《中华人民共和国公司法》、《中华人民共和国证券法》、《上 海证券交易所股票上市规则》《上市公司投资者关系管理工作指引》等有关法律、 法规、规范性文件和《湖北均瑶大健康饮品股份有限公司章程》（ 以下简称"《公 司章程》"）的规定，结合公司的实际情况，特制定本制度。 湖北均瑶大健康饮品股份有限公司 第二条 投资者关系管理是指公司通过便利股东权利行使、信息披露、互动 交流和诉求处理等工作，加强与投资者及潜在投资者之间的沟通，增进投资者对 公司的了解和认同，以提升公司治理水平和企业整体价值，实现尊重投资者、回 报投资者、保护投资者目的的相关活动。 第三条 公司开展投资者关系管理工作应体现公平、公正、公开原则，平等 对待全体投资者，保障所有投资者享有知情权及其他合法权益。 第四条 公司开 ...